Sarah Krug, MS

CEO, Cancer101 Inc & President, Society for Participatory Medicine


Ms. Krüg, CEO, CANCER101, a patient advocacy organization. She has been on the board of for three years, in a quest to help patients and caregivers navigate the cancer journey. She is also President-Elect of the Society for Participatory Medicine, a patient/provider member driven organization whose mission is to enable collaborative partnerships between patients and healthcare professionals. She serves on the board and as Research Chair of the Cancer Patient Education Network, an organization created by NCI to provide a framework for patient educators across institutions worldwide. She is also on the CPEN Health Literacy Committee.  She previously held the position of Global Education Director in the Medical Education Group at Pfizer, focused on establishing global health care improvement strategies and medical education standards worldwide. She also established the Global Investigator Initiated Research Program at Pfizer.  Prior to joining Pfizer, Sarah spearheaded the development of the Pediatric Disease Management clinical pathways and conducted clinical research at Memorial Sloan- Kettering Cancer Center. In her spare time, Sarah enjoys writing and is contributing writer for Pharmaceutical Executive.